The goal of this clinical trial is to evaluate the feasibility, safety and effectiveness of radiotherapy with fewer days of treatment and a higher dose of radiation each day in patients under 70 years of age diagnosed with a brain tumor known as glioblastoma.
Initial histological diagnosis of glioblastoma
Age > 18 and < 70 years;
Karnofsky Performance Status > 70%;
Patient consent to participate in the study.
Patients submitted to any type of previous radiotherapy in the cranial region;
Multicentric tumors;
Contraindication to chemotherapy with temozolomide;
Contraindications for performing magnetic resonance imaging (MRI), such as the use of implants or metallic prostheses;